GlobeNewswire

Mitsubishi Heavy Industries to Acquire Canadair Regional Jet Program from Bombardier Inc.

Share
  • MHI now positioned to transform and lead the underserved regional jet business , with bolster ed customer support services
  • Key step in MHI’s strategy of expanding its aircraft business globally, with a mid-term focus on North America
  • Completes Bombardier’s aerospace transformation and refocus on business aviation

TOKYO and MONTRÉAL, June 25, 2019 (GLOBE NEWSWIRE) -- Mitsubishi Heavy Industries, Ltd (MHI) (TOKYO:7011) and Bombardier Inc (TSX: BBD.B) announced today they have entered into a definitive agreement, whereby MHI will acquire Bombardier’s regional jet program for a cash consideration of $550 million USD, payable to Bombardier upon closing, and the assumption by MHI of liabilities amounting to approximately $200 million USD. Under the agreement, Bombardier’s net beneficial interest in the Regional Aircraft Securitization Program (RASPRO), which is valued at approximately $180 million USD, will be transferred to MHI.

Pursuant to the agreement, MHI will acquire the maintenance, support, refurbishment, marketing, and sales activities for the CRJ Series aircraft, including the related services and support network located in Montréal, Québec, and Toronto, Ontario, and its service centres located in Bridgeport, West Virginia, and Tucson, Arizona, as well as the type certificates.

This acquisition is complementary to MHI’s existing commercial aircraft business, in particular the development, production, sales and support of the Mitsubishi SpaceJet commercial aircraft family. The maintenance and engineering capabilities of the CRJ program will further enhance critical customer support functions, a strategic business area for MHI in the pursuit of future growth.

Seiji Izumisawa, President & CEO of Mitsubishi Heavy Industries Ltd., commented: “As we outlined during the recent Paris Air Show, we are working hard to ensure that we provide new profit potential for airlines and set a new standard for passenger experience. This transaction represents one of the most important steps in our strategic journey to build a strong, global aviation capability. It augments these efforts by securing a world-class and complementary set of aviation-related functions including maintenance, repair and overhaul (MRO), engineering and customer support.”     

Izumisawa concluded, “The CRJ program has been supported by tremendously talented individuals. In combination with our existing infrastructure and resources in Japan, Canada and elsewhere, we are confident that this represents one effective strategy that will contribute to the future success of the Mitsubishi SpaceJet family. MHI has a decades-long history in Canada, and I hope this transaction will result in the expansion of our presence in the country, and will represent a significant step in our growth strategy.”

“We are very pleased to announce this agreement, which represents the completion of Bombardier’s aerospace transformation,” said Alain Bellemare, President and Chief Executive Officer, Bombardier Inc. “We are confident that MHI’s acquisition of the program is the best solution for airline customers, employees and shareholders. We are committed to ensuring a smooth and orderly transition.” 

Bellemare continued: “With our aerospace transformation now behind us, we have a clear path forward and a powerful vision for the future. Our focus is on two strong growth pillars: Bombardier Transportation, our global rail business, and Bombardier Aviation, a world-class business jet franchise with market-defining products and an unmatched customer experience.”

The CRJ production facility in Mirabel, Québec will remain with Bombardier. Bombardier will continue to supply components and spare parts and will assemble the current CRJ backlog on behalf of MHI. CRJ production is expected to conclude in the second half of 2020, following the delivery of the current backlog of aircraft.

Bombardier will also retain certain liabilities representing a portion of the credit and residual value guarantees totaling approximately $400 million USD. This amount is fixed and not subject to future changes in aircraft value, and payable by Bombardier over the next four years.

The transaction is currently expected to close during the first half of 2020 and remains subject to regulatory approvals and customary closing conditions.

The agreement contemplates a reverse break fee payable by MHI under certain circumstances.

About MHI
Mitsubishi Heavy Industries, Ltd. (MHI), headquartered in Tokyo, is one of the world’s leading industrial firms with 80,000 group employees and annual consolidated revenues of around US$38 billion. For more than 130 years, the company has channeled big thinking into innovative and integrated solutions that move the world forward. MHI owns a unique business portfolio covering land, sea, sky and even space. MHI delivers innovative and integrated solutions across a wide range of industries from commercial aviation and transportation to power plants and gas turbines, and from machinery and infrastructure to integrated defense and space systems.

For more information, please visit MHI’s website: www.mhi.com/index.html

About Bombardier
With over 68,000 employees, Bombardier is a global leader in the transportation industry, creating innovative and game-changing planes and trains. Our products and services provide world-class transportation experiences that set new standards in passenger comfort, energy efficiency, reliability and safety.

Headquartered in Montreal, Canada, Bombardier has production and engineering sites in 28 countries as well as a broad portfolio of products and services for the business aviation, commercial aviation and rail transportation markets. Bombardier shares are traded on the Toronto Stock Exchange (BBD). In the fiscal year ended December 31, 2018, Bombardier posted revenues of $16.2 billion US. The company is recognized on the 2019 Global 100 Most Sustainable Corporations in the World Index. News and information are available at bombardier.com or follow us on Twitter @Bombardier.

Bombardier and CRJ are trademarks of Bombardier Inc. or its subsidiaries.

For Information

Olivier Marcil
Vice President
External Communications
Bombardier Inc.
+514 861 2610
Patrick Ghoche
Vice President,
Investor Relations
Bombardier Inc.
+514 861 5727

Corporate Communication Department
Mitsubishi Heavy Industries, Ltd.
mediacontact_global@mhi.co.jp

 

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Scanship Holding ASA : Invitation to 3Q2019 Trading update on Tuesday 22 October14.10.2019 21:52:00 CESTPress release

Welcome to Scanship Holding ASA's 3Q2019 Trading update at hrs. 12.00 on Tuesday 22 October in Oslo. With the recent acquisition of ETIA, Scanship has significantly broadened and expanded its adressable market, and the presentation will include more insight to forward growth strategies within the various landbased markets. Special attention will be given on Scanship's value proposition for the European biogas market and within chemical recycling of plastic waste. The presentation will be held at MESH in Tordenskioldsgate 3, and a light lunch will be served. Please notify Scanship by e-mail to attend: erik.magelssen@scanship.no, or cell + 47 928 88 728 Venue: MESH, the Lounge, Tordenskiolds gate 3, 0160 Oslo For further queries, please contact: Henrik Badin - CEO Scanship Holding ASA Tel: +47 90 78 98 25 Email: henrik.badin@scanship.no ABOUT SCANSHIP HOLDING ASA Scanship delivers world leading solutions for cleaner oceans in the Cruise and Aquaculture industries. Scanship provides advan

Notice of extraordinary general meeting in Oasmia Pharmaceutical AB14.10.2019 20:48:00 CESTPress release

The shareholders of Oasmia Pharmaceutical AB (the “Company”) are hereby given notice of the extraordinary general meeting on Wednesday 6 November 2019, at 14:00 CET, at the offices of the Company, Vallongatan 1, 752 28 Uppsala. The registration opens at 13:30 CET. NOTICE OF ATTENDANCE Shareholders who wish to participate in the general meeting must be recorded in the share register kept by Euroclear Sweden AB as of Wednesday 30 October 2019 and give notice of intent to participate to the Company no later than on Wednesday 30 October 2019, either by letter to Oasmia Pharmaceutical AB, Vallongatan 1, 752 28 Uppsala, Sweden, by facsimile: +46 (0)18-51 08 73 or by e-mail: info@oasmia.com, and specify the number of advisors (maximum two). If shareholder’s attendance and right at the meeting will be exercised by proxy, we would be grateful if such is provided in connection with the notification of attendance. A proxy form is available to shareholders upon request and is avaliable at the Comp

Kallelse till extra bolagsstämma i Oasmia Pharmaceutical AB14.10.2019 20:48:00 CESTPressemelding

Aktieägarna i Oasmia Pharmaceutical AB (”Bolaget”) kallas härmed till extra bolags­stämma onsdagen den 6 november 2019 kl. 14:00, i Bolagets lokaler, Vallongatan 1, 752 28 Uppsala. Inregistrering påbörjas kl. 13:30. ANMÄLAN Aktieägare som önskar delta vid bolagsstämman skall dels vara införd i den av Euroclear Sweden AB förda aktieboken onsdagen den 30 oktober 2019, dels anmäla sitt deltagande till Bolaget senast onsdagen den 30 oktober 2019 under adress Oasmia Pharmaceutical AB, Vallongatan 1, 752 28 Uppsala, per fax: 018-51 08 73 eller via e-post: info@oasmia.com, varvid antalet biträden skall anges (högst två). Om deltagande skall ske med stöd av fullmakt är vi tacksamma om sådan ges in redan i samband med anmälan. Fullmakten får inte vara äldre än ett år gammal, dock att fullmakten får vara äldre än ett år om det framgår att den är giltig för en längre period, längst fem år. Fullmaktsformulär tillhandahålls aktieägare på begäran och finns tillgängligt hos Bolaget och på Bolagets we

The Board of Directors in Oasmia proposes a rights issue of approximately SEK 400 million14.10.2019 20:46:00 CESTPress release

The Board of Directors in Oasmia Pharmaceutical AB (”Oasmia” or the ”Company”) today announces a notice to an extra general meeting on 6 November 2019. It is proposed that the extra general meeting resolves to authorise the Board of Directors to carry out a rights issue of approximately SEK 400 million (the “Rights Issue”). The proceeds from the Rights Issue will primarily be used to finance and accelerate the commercialization of Apealea® and capture new business opportunities based on the Company's proprietary XR17 platform. Moreover, Oasmia intends to create a stable financial position enabling a solid platform for growth. The Company’s major shareholder Per Arwidsson through Arwidsro Investment AB and related parties (“Arwidsro”) has undertaken to subscribe for its pro-rata share in the Rights Issue, corresponding to approximately SEK 100 million or 25 percent. Oasmia has also received a financing commitment from Arwidsro enabling Oasmia to repay the convertible loan on 31 October

Styrelsen i Oasmia föreslår en företrädesemission om cirka 400 MSEK14.10.2019 20:46:00 CESTPressemelding

Styrelsen i Oasmia Pharmaceutical AB (”Oasmia” eller ”Bolaget”) offentliggör idag kallelse till extra bolagsstämma den 6 november 2019. Bolagsstämman föreslås besluta att bemyndiga styrelsen att genomföra en företrädesemission om cirka 400 MSEK (”Företrädesemissionen”). Likviden från Företrädesemissionen ska huvudsakligen användas för att finansiera och accelerera kommersialiseringen av Apealea® samt tillvarata nya affärsmöjligheter baserade på Bolagets egenutvecklade XR17-plattform. Därutöver avser Oasmia att skapa en stabil finansiell position för att möjliggöra framtida tillväxt. Bolagets största aktieägare Per Arwidsson via Arwidsro Investment AB och närstående (”Arwidsro”) har åtagit sig att teckna sig för sin pro rata-andel i Företrädesemissionen, motsvarande cirka 100 MSEK eller 25 procent. Oasmia har också fått ett finansieringsåtagande från Arwidsro som möjliggör för Oasmia att återbetala det utestående konvertibellånet den 31 oktober 2019. Sammanfattning Styrelsen offentliggö

Arion Bank: Discontinued operations and assets held for sale have negative impact on Q3 2019 financial results14.10.2019 20:29:00 CESTPress release

Discontinued operations and assets held for sale will have a negative impact of approximately ISK 3 billion after tax on Arion Bank’s Q3 2019 financial results, compared with a loss of ISK 715 million in Q2 2019. Discontinued operations held for sale refer to assets or companies which the Bank intends to sell in the next few months and are placed below net earnings from continuing operations in the income statement. Increased losses in the quarter are attributable to three factors: As a result of the challenging markets, including the low global price of silicon, Arion Bank is making an impairment of ISK 1.5 billion in respect of assets owned by Stakksberg. Stakksberg is a holding company for the silicon plant at Helguvík which is in the process of being sold. Preparations to sell the plant have been ongoing and an environmental impact assessment has been commissioned and new agreements with energy companies negotiated. Due to difficult conditions in the travel industry, Arion Bank is